• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners.

出版信息

Occas Pap R Coll Gen Pract. 1992 Mar(55):1-15.

PMID:1296829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2560093/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43a/2560093/8b1b99d704af/occpaper00109-0009-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43a/2560093/be0c5f2d368c/occpaper00109-0009-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43a/2560093/8b1b99d704af/occpaper00109-0009-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43a/2560093/be0c5f2d368c/occpaper00109-0009-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43a/2560093/8b1b99d704af/occpaper00109-0009-b.jpg

相似文献

1
Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners.全科医疗中高脂血症管理指南。迈向冠心病的一级预防。皇家全科医师学院。
Occas Pap R Coll Gen Pract. 1992 Mar(55):1-15.
2
Management of hyperlipidaemia.
Aust Fam Physician. 2005 Jun;34(6):447-53.
3
Attitudes and practice of New Zealand doctors in the management of patients with dyslipidaemia.
N Z Med J. 1993 Jun 23;106(958):243-7.
4
General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia.全科医生对高脂血症患者治疗益处和成本的看法。
Br J Gen Pract. 1998 Feb;48(427):983-4.
5
Involvement of the primary health care team in coronary heart disease prevention.初级卫生保健团队在冠心病预防中的参与。
Br J Gen Pract. 1994 May;44(382):224-8.
6
Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.德国全科医疗中通过降脂治疗进行心血管疾病的一级预防：全科医生忽视指南和风险计算器的结果。
Eur J Gen Pract. 2007;13(1):27-34. doi: 10.1080/13814780601050541.
7
[Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].[法国血脂异常患者管理不当。奥德赛研究结果]
Arch Mal Coeur Vaiss. 2004 Mar;97(3):187-93.
8
Can audit of a local protocol for the management of lipid disorders effect and detect a change in clinical practice?
Health Bull (Edinb). 1997 Mar;55(2):94-102.
9
[Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].[冠心病的一级和二级预防。国际冠心病预防特别工作组立场文件]
Dtsch Med Wochenschr. 2000 Jul 14;125(28-29):881-7. doi: 10.1055/s-2000-7022.
10
The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.成人高脂血症的识别与管理：欧洲动脉粥样硬化学会政策声明
Eur Heart J. 1988 May;9(5):571-600.

引用本文的文献

1
A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group.一项聚焦于促进身体活动和健康生活方式的瑞典初级卫生保健预防计划降低了心血管事件和死亡率：5761 名研究参与者和对照组的 22 年随访结果。
Br J Sports Med. 2020 Nov;54(21):1294-1299. doi: 10.1136/bjsports-2019-101749. Epub 2020 Jul 17.
2
Screening for hypercholesterolaemia in primary care: randomised controlled trial of postal questionnaire appraising risk of coronary heart disease.基层医疗中高胆固醇血症的筛查：评估冠心病风险的邮政问卷随机对照试验。
BMJ. 1998 Apr 18;316(7139):1208-13. doi: 10.1136/bmj.316.7139.1208.

本文引用的文献

1
Risk of cancer and death in relation to serum cholesterol. A longitudinal study in an eastern Finnish population with high overall cholesterol level.
Am J Epidemiol. 1982 Oct;116(4):622-30. doi: 10.1093/oxfordjournals.aje.a113445.
2
General practice compliance study: is it worth being a personal doctor?全科医疗依从性研究：成为私人医生值得吗？
Br Med J (Clin Res Ed). 1981 Apr 11;282(6271):1192-4. doi: 10.1136/bmj.282.6271.1192.
3
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.考来烯胺治疗对冠状动脉粥样硬化进展的影响：美国国立心肺血液研究所II型冠状动脉干预研究结果
Circulation. 1984 Feb;69(2):313-24. doi: 10.1161/01.cir.69.2.313.
4
Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial.
Lancet. 1983 Sep 17;2(8351):639-42. doi: 10.1016/s0140-6736(83)92527-8.
5
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.饮食与吸烟干预对冠心病发病率的影响。奥斯陆健康男性随机试验研究小组的报告。
Lancet. 1981 Dec 12;2(8259):1303-10. doi: 10.1016/s0140-6736(81)91338-6.
6
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.血清胆固醇、脂蛋白与冠心病风险。弗雷明汉姆研究。
Ann Intern Med. 1971 Jan;74(1):1-12. doi: 10.7326/0003-4819-74-1-1.
7
Colon cancer and blood-cholesterol.结肠癌与血液胆固醇
Lancet. 1974 Feb 9;1(7850):181-3. doi: 10.1016/s0140-6736(74)92492-1.
8
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study.缺血性心脏病的风险因素：英国地区心脏研究的前瞻性阶段
J Epidemiol Community Health. 1985 Sep;39(3):197-209. doi: 10.1136/jech.39.3.197.
9
Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.血清中总胆固醇和高密度脂蛋白胆固醇与死亡风险：阈值效应的证据。
Br Med J (Clin Res Ed). 1985 Apr 27;290(6477):1239-43. doi: 10.1136/bmj.290.6477.1239.
10
[Strategy for the prevention of ischemic heart disease. Directives from the European Society of Atherosclerosis].[缺血性心脏病的预防策略。欧洲动脉粥样硬化学会指南]
Rev Esp Cardiol. 1987 Jan-Feb;40(1):8-9.